食神鞘氨醇杆菌（Sphingo spiritivorum）肝素酶的制备和性质研究

doi:10.13560/j.cnki.biotech.bull.1985.2016-1162

摘要/Abstract

摘要： 筛选新型肝素酶产生菌,制备新型肝素酶并对其降解肝素能力进行测试。采用定向富集方法对土壤中的菌群进行培养,筛选分离产肝素酶的新种菌株,利用微生物发酵和蛋白纯化技术制备肝素酶,考察新型肝素酶的理化性质和酶切位点,之后使用新型肝素酶降解肝素并测试产物特征。筛选分离得到1株新的肝素酶产生菌,属食神鞘氨醇杆菌（Sphingo spiritivorum）。发酵后得到的粗酶,经多步柱层析纯化后得到的新型肝素酶SShepI和SShepII,用得到的酶降解肝素得到两种新型酶制低分子肝素。利用食神鞘氨醇杆菌中分离纯化得到的两种新型肝素酶SShepI和SShepII制备的新型酶制低分子肝素,有望开发成抗凝血效果更佳或具有新临床功能的低分子肝素药物。

关键词: 食神鞘氨醇杆菌, 肝素酶, 制备, 性质

Abstract: This work aims to screen new type of strain producing novel heparinase,and to prepare novel heparinase and test its ability of degrading heparin. The bacteria in soil were cultured using the directional enrichment method,and strains producing heparinase were isolated. Microbial fermentation and purification technology were adopted to prepare novel heparinase,and to study the physical and chemical properties and the cleavage site of novel heparinase. Then,the heparinase were applied to degrade heparin,and the obtained low molecular weight heparins（LMWHs）were characterized. A new heparinase-producing strain belonging to the genus of Sphingo spiritivorum was isolated. The crude enzyme after fermentation was purified with multi-step column chromatography and novel heparinase SShepI and SShepII were obtained,with which two kinds of novel low molecular weight heparins were generated by the degradation of heparin. Conclusively,novel heparinase SShepI and SShepII isolated and purified from a strain of S. spiritivorum are adopted to degrade heparin for preparing low molecular weight heparins,which are expected to be developed into LMWH drugs with better anticoagulant effect or new clinical function.

Key words: Sphingo spiritivorum, heparinase, preparation, characterization

尹思远,白佳珂,李锂,马小来. 食神鞘氨醇杆菌（Sphingo spiritivorum）肝素酶的制备和性质研究[J]. 生物技术通报, 2017, 33(9): 244-251.

YIN Si-yuan,BAI Jia-ke,LI Li,MA Xiao-lai. Preparation and Characterization of Novel Heparinase from Sphingo spiritivorum[J]. Biotechnology Bulletin, 2017, 33(9): 244-251.

参考文献

[1] Gray E, Mulloy B, Barrowcliffe TW. Heparin and low-molecular-weight heparin[J] . Thrombo Haemost, 2008, 99（5）：807-818.
[2] Fareed J, Ma Q, Florian M, et al. Differentiation of low molecular-weight heparins：impact on the future of the management of thrombosis[J] . Semin Thromb Hemost, 2004, （30 Suppl. 1）：89-104.
[3] 杨明康, 李晓燕, 钱捷, 等. 低分子量肝素的研究进展[J] . 齐鲁药事, 2012, 31（11）：663-666.
[4] 李晔, 吴敬君, 叶逢春, 等. 肝素黄杆菌肝素酶Ⅲ基因hepC 的可溶表达体系构建及酶学性质研究[J] . 2013, （6）：133-139.
[5] Ma XL, Wang ZS, Li SX, et al. Effect of CaCl2 as activity stabilizer on purification of heparinase I from Flavobacterium heparinum[J] . Journal of Chromatography B, 2006, （843）：209-215.
[6] Kazuyuki S. Characterization of heparinase from an oral bacterium Prevotella heparinolytica[J] . J Biochem, 1998, 123（2）：283-288.
[7] 高宁国, 程秀兰, 杨敬, 等. 肝素酶产生菌的筛选及发酵条件[J] . 微生物学报, 1999, 39（1）：64-67.
[8] Yoshida E, Sakai K, Tokuyam S, et al. Purification and characteriz-ation of heparinase that degrades both heparin and heparin sulfate from Bacillus circulans[J] . Biosci Biotechnol Biochem, 2002, 66（5）：1181-1184.
[9] 罗璠, 王忠彦, 等. 肝素酶产生菌的筛选及其粗酶性质的研究[J] . 四川大学学报：自然科学版, 2002, 39（4）：777-779.
[10] 高宁国, 程秀兰, 杨敬, 等. 鞘胺醇杆菌肝素酶的产生[J] . 微生物学报, 2003, 43（6）：813-816.
[11] Kim DH. Purification and characterization of a novel heparinase from Bacteroides stercoris HJ-15[J] . Journal of Biochemistry, 2000, 128（2）：323-328.
[12] Lowry OH, Roscbrough NJ, Farr AL, et al. Protein measurement with the folin phenol regent[J] . Journal of Biological Chemistry, 1951, 193（1）：265-275.
[13] 何忠效、张树政. 电泳[M] . 第2版. 北京：科学出版社, 1999, 127-130.
[14] The united states Pharmacopeial convention. USP 2003, U. S. A. ：United Stated Pharmacopeial Convention, 2003：USP39-NF34. Chemical Test and Assays <209> 232-233.
[15] The united states Pharmacopeial convention. USP 2003, U. S. A. ：United Stated Pharmacopeial Convention, 2003：USP39-NF34. Chemical Test and Assays <208> 230-232.
[16] Daniel LL, Robert JL. Purification and characterizatioonf heparin lyases from Flavobacterium heparinurn[J] . The Journal of Biological Chemistry, 1992, 267（34）：24347-2435.
[17] Hyun YJ, Lee JH, et al. Cloning, overexpression, and characteriz-ation of recombinant heparinase III from Bacteroides stercoris HJ-15[J] . Appli Microbiol Bi?technol, 2010, 86：879-890.
[18] Kim WS, Kim BT, Kim DH, et al. Purification and characterization of heparin lyase I from Bacteroides stercoris HJ-15[J] . Journal of Biochemistry and Molecular Biology, 2004, 37（6）：684-690.
[19] Nakamura T, Suginaka Y, Takazoe I. Heparinase activity in lesion of periodontal diseases[J] . Bulletin of Tokyo Dental College, 1976, 17：147-155.
[20] Yoshida E, Arakawa S, Matsunaga T, et al. Cloning, sequencing, and expression of the gene from Bacillus circulans that codes for a heparinase that degrades both heparin and heparan sulfate[J] . Biosci Biotechnol Biochemi, 2002, 66：1873-1879.
[21] Nakamura T, Shibata Y, Fujimura S. Purification and properties of Bacteroides heparinolyticus heparinase（heparin lyase, EC 4. 2. 2. 7）[J] . J Clin Microbiol, 1988, （26）：1070-1071.
[22] Bohmer LH, Pitout MJ, Steyn PL, et al. Purification and characterization of a novel heparinase[J] . Journal of Biological Chemistry, 1990, 265：13609-13617.
[23] Banga J, Tripathi CK. Purification and characterization of a novel heparin degrading enzyme from Aspergillus flavus（MTCC-8654）[J] . Appl Environm Microbiol, 2010, 160：1004-1016.
[24] Banga J, Tripathi CK. Rapid purification and characterization of a novel heparin degrading enzyme from Acinetobacter calcoaceticus[J] . New Biotechnology, 2009, 26（11）：100-104.
[25] Maraveyas A, Johnson MJ, et al. Malignant melanoma as a target malignancy for the study of the antimetastatic properties of the heparins[J] . Cancer Metastasis Rev, 2010, 29（4）：777-784.
[26] Luo JY, Zhong Y, Cao JC, et al. Efficacy of oral colon-specific delivery capsule of low-molecular-weight heparin on ulcerative colitis[J] . Biomed Pharmacother, 2011, 65（2）：111-117.
[27] Kupferminc M, Rimon E, Many A, et al. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia[J] . Blood Coagul Fibrinolysis, 2011, 22（2）：123-126.